Covid-19 rebound affects 1 in 5 people after taking Paxlovid

Covid-19 rebound, when the virus increases in the body after initially decreasing, affected just under 21 per cent of people after they took Paxlovid in a trial, compared with fewer than 2 per cent not on the treatment

​Covid-19 rebound, when the virus increases in the body after initially decreasing, affected just under 21 per cent of people after they took Paxlovid in a trial, compared with fewer than 2 per cent not on the treatment Covid-19 rebound, when the virus increases in the body after initially decreasing, affected just under 21 per cent of people after they took Paxlovid in a trial, compared with fewer than 2 per cent not on the treatment